Compass Pathways Clears Another Hurdle – Builds Stronger FDA Case For Its Much-Awaited Depression Therapy
Among patients receiving a 25 mg dose, 39% achieved a clinically meaningful reduction in depression symptoms by Week…
New affordable AMOLED smartwatch packs dual-band six-satellite GPS and free stainless-steel strap
Rogbid’s Apex HD is another new budget outdoor smartwatch priced at $59.99. It’s targeted more towards the “activity…
Does FDA’s Rolling Review Of COMP360 Psilocybin Depression Therapy Change The Bull Case For COMPASS Pathways (CMPS)?
In April 2026, COMPASS Pathways announced that the FDA granted a rolling NDA review for its synthetic psilocybin…
How AI can and can’t help you with your finances – Diana Clement
It’s very good at helping you create rules for your financial situation. Such as: No purchase over $x…
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
LONDON & NEW YORK, January 06, 2026–(BUSINESS WIRE)–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating…
How the “new-collar” workforce is shaping the future of AI and digital infrastructure
The U.S. is in the middle of a digital infrastructure revolution. Artificial intelligence, cloud computing, and edge technologies…
Genomenon and Compass Bioinformatics Partner to Transform Genomic Diagnostics in the U.S. and Japan
Mastermind® FLEX Data powers Compass Bioinformatics’s InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan,…